MBCL-03. RESULTS OF HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA

AIM: Medulloblastoma is a highly lethal disease when it recurs. Very few patients survive with second line conventional treatment after relapse. This study evaluated the use of high-dose thiotepa, carboplatin and etoposide with autologous hematopoietic stem-cell transplantation (HSCT) in patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Gevorgian, Asmik, Tolkunova, Polina, Kazantsev, Ilya, Iukhta, Tatiana, Kozlov, Andrew, Zvyagintseva, Darya, Morozova, Elena, Zubarovskaya, Ludmila, Afanasiev, Boris, Zheludkova, Olga, Punanov, Yury
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Medulloblastoma (Clinical)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715147/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.479
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados